NBI-74788
NBI-74788-CAH2011
Phase 2 small_molecule active
Quick answer
NBI-74788 for Congenital adrenal hyperplasia (CAH) is a Phase 2 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Congenital adrenal hyperplasia (CAH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active